Department of Biostatistics, Singapore Clinical Research Institute, Singapore, Singapore.
Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.
Patient. 2019 Aug;12(4):383-392. doi: 10.1007/s40271-018-00354-7.
BACKGROUND: It is not clear whether 5-level EQ-5D (EQ-5D-5L) utilities based on recently developed value sets are more responsive than 3-level EQ-5D (EQ-5D-3L) utilities. OBJECTIVES: The study aims were to compare (1) the responsiveness of EQ-5D-5L and EQ-5D-3L utilities and (2) the responsiveness of these utilities with the Short Form-6 Dimension (SF-6D) and Health Utilities Index Mark 3 (HUI3) utilities to the treatment benefit of cataract surgery. METHODS: A total of 148 patients were interviewed before and after their cataract surgery using EQ-5D-3L, EQ-5D-5L, SF-6D, and HUI3. Responsiveness was assessed for all measures using the mean change (post-treatment-pre-treatment), standardized effect size (SES), standardized response mean (SRM), and F-statistic. RESULTS: Using the Singapore value sets, mean change for EQ-5D-3L and EQ-5D-5L utilities was 0.016 and 0.028, SES was 0.097 and 0.199; SRM was 0.091 and 0.196; and F-statistic was 1.2 and 5.7, respectively. Similar trends were observed using the UK/England EQ-5D value sets, although the magnitude was slightly smaller. The mean change, SES, SRM and F-statistics for SF-6D (UK value set) were 0.020, 0.234, 0.249, and 9.2, respectively. The values of mean change, SES, SRM and F-statistics for HUI3 (Canada value set) were 0.080, 0.472, 0.474, and 33.3, respectively. CONCLUSIONS: The EQ-5D-5L utilities tend to be more responsive than the EQ-5D-3L utilities to treatment benefits of cataract surgery. The HUI3 utilities are more responsive than both the EQ-5D-5L and SF-6D, and SF-6D utilities may be slightly more responsive than the EQ-5D-5L for assessing patients undergoing cataract surgery.
背景:目前尚不清楚基于最近开发的价值体系的 5 级 EQ-5D(EQ-5D-5L)效用是否比 3 级 EQ-5D(EQ-5D-3L)效用更具反应性。
目的:本研究旨在比较(1)EQ-5D-5L 和 EQ-5D-3L 效用的反应性,以及(2)这些效用与短期表格-6 维度(SF-6D)和健康效用指数马克 3(HUI3)效用对白内障手术治疗效果的反应性。
方法:共 148 例患者在接受白内障手术后使用 EQ-5D-3L、EQ-5D-5L、SF-6D 和 HUI3 进行了采访。使用平均变化(治疗后-治疗前)、标准化效应量(SES)、标准化反应均值(SRM)和 F 统计量评估所有指标的反应性。
结果:使用新加坡价值体系,EQ-5D-3L 和 EQ-5D-5L 效用的平均变化分别为 0.016 和 0.028,SES 分别为 0.097 和 0.199;SRM 分别为 0.091 和 0.196;F 统计量分别为 1.2 和 5.7。使用英国/英格兰 EQ-5D 价值体系观察到类似的趋势,尽管幅度略小。SF-6D(英国价值体系)的平均变化、SES、SRM 和 F 统计量分别为 0.020、0.234、0.249 和 9.2。HUI3(加拿大价值体系)的平均变化、SES、SRM 和 F 统计量分别为 0.080、0.472、0.474 和 33.3。
结论:EQ-5D-5L 效用比白内障手术治疗效果更能反映 EQ-5D-3L 效用。HUI3 效用比 EQ-5D-5L 和 SF-6D 更具反应性,而 SF-6D 效用在评估接受白内障手术的患者时可能比 EQ-5D-5L 更具反应性。
Eur J Health Econ. 2015-12
Med Decis Making. 2018-11
Qual Life Res. 2015-6
Expert Rev Pharmacoecon Outcomes Res. 2021-8
Pharmacoeconomics. 2025-8-29
Health Qual Life Outcomes. 2025-8-22
Health Qual Life Outcomes. 2021-5-28
Qual Life Res. 2021-3
Eur J Health Econ. 2018-6-14
Pharmacoeconomics. 2018-6
Health Econ. 2018-1
J Cataract Refract Surg. 2016-12
Value Health Reg Issues. 2016-5
Pharmacoeconomics. 2016-10